{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["16(18)"],"submitter":["Isaacs JT"],"funding":["NCI NIH HHS"],"journal":["Cell cycle (Georgetown, Tex.)"],"pagination":["1639-1640"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5602292"],"repository":["biostudies-literature"],"pubmed_title":["Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer."],"pmcid":["PMC5602292"],"funding_grant_id":["R01 CA184012"],"pubmed_authors":["Isaacs JT","Denmeade SR","Brennen WN"],"additional_accession":[]},"is_claimable":false,"name":"Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer.","description":null,"dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Sep","modification":"2025-05-29T16:29:53.461Z","creation":"2025-04-04T07:42:26.884Z"},"accession":"S-EPMC5602292","cross_references":{"pubmed":["28820291"],"doi":["10.1080/15384101.2017.1360645"]}}